Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment
Crossref DOI link: https://doi.org/10.1186/1471-2474-15-256
Published Online: 2014-07-28
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Majorczyk, Edyta
Pawlik, Andrzej
Gendosz, Daria
Kuśnierczyk, Piotr
Text and Data Mining valid from 2014-07-28
Article History
Received: 26 August 2013
Accepted: 30 June 2014
First Online: 28 July 2014